Ocular amyloidosis and secondary glaucoma

Ophthalmology

Volumn 106, Issue 7, 1999, Pages 1363-1366

  Nelson, Gregory A ^a   Edward, Deepak P ^a,b   Wilensky, Jacob T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Ophthalmology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIGLAUCOMA AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPIVEFRINE; PILOCARPINE; TIMOLOL;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; ORBIT DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY GLAUCOMA; TREATMENT OUTCOME; VISUAL FIELD;

EID: 0033498182     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)00726-5     Document Type: Article

References (13)

1. Bansal RK, Gupta A, Agarwal A. Primary orbital amyloidosis with secondary glaucoma. A case report. Orbit 1991;10: 105-8.
2. Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173-96.
3. Ando E, Ando Y, Okamura R, et al. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 1997;81:295-8.
4. Futa R, Inada K, Nakashima H, et al. Familial amyloidotic polyneuropathy: ocular manifestations with clinicopathological observation. Jpn J Ophthalmol 1984;28:289-98.
5. Kaufman HE. Primary familial amyloidosis. Arch Ophthalmol 1958;60:1036-143.
6. Tsukahara S, Matsuo T. Secondary glaucoma accompanied with primary familial amyloidosis. Ophthalmologica 1977; 175:250-62.
7. Zeimer RC, Gieser DK, Wilensky JT, et al. A practical venomanometer. Measurement of episcleral venous pressure and assessment of the normal range. Arch Ophthalmol 1983; 101:1447-19.
8. Levine MR, Buckman G. Primary localized orbital amyloidosis. Ann Ophthalmol 1986;18:165-7.
9. Andrade C. A peculiar form of peripheral neuropathy. Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-27.
10. Ueno S, Uemichi T, Yorifuji S, Tarui S. A novel variant of transthyretin (Tyr 114 to Cys) deduced from the nucleotide sequences of gene fragments from familial amyloidotic polyneuropathy in Japanese sibling cases. Biochem Biophys Res Commun 1990;169:143-7.
11. Ciulla TA, Tolentino F, Morrow JF, Dryja TP. Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation. Surv Ophthalmol 1995;40:197-206.
12. Doft BH, Machemer R, Skinner M, et al. Pars plana vitrectomy for vitreous amyloidosis. Ophthalmology 1987;94:607-11.
13. Ando E, Ando Y, Maruoka S, et al. Ocular microangiopathy in familial amyloidotic polyneuropathy, type 1. Graefes Arch Clin Exp Ophthalmol 1992;230:1-5.